MRD / Regn No. : THBC\23-24\04339 Date : 22/01/2025
Patient Name : Manish Atal Age & Gender : 56 Yrs. / Male
Contact No. : 8879067774 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (13/Jun/2020) | HYPOTHYROIDISM (13/Jun/2020) | HTN (13/Apr/2024) | DYSLIPIDEMIA (13/Apr/2024) |
Subjective : T2DM SINCE 2020,HYPOTHYROIDISM SINCE 2020,HTN/ DYSLIPIDEMIA SINCE APRIL 24,B12/ D SUPPLEMENTED,WALKED 45 MINS / 25 MINS TWICE DAILY,STOPPED EATING OUTSIDE FREQUENTLY / STOPPED GENERIC MEDS,LAST HBA1C-6.82%
Objective : 19-JAN-2025 REPORTS,HBA1C-6.6%,FBS-130/ PPBS-192
S# Generic (Trade) Name Route Dosage Usage Duration
1 THYROCIP 50 ORAL 1-0-0 BBF
4 MTHS
2 TELISTA 40 MG ORAL 1-0-0 ABF
4 MTHS
3 TABLET SITAGLIPTIN (50MG) + METFORMIN (500)
STALIX M 50/500
Medicine For T2DM
ORAL 1-0-1 BBF / BD
4 MTHS
4 GLIMISAVE M1 ORAL 1-0-1 BBF / BD
4 MTHS
5 ROSEDAY A 10+75 MG ORAL 0-0-1 AD
4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 10/Jan/2025
Tests Suggested For Next Visit : FBS / PPBS. / HBA1C > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: